Neurohormonal Therapy in Patients With Transthyretin Cardiac Amyloidosis: Is it an Option?
- DOI
- 10.1016/j.jaccas.2026.110244
- Published
- 2026 Sep 23
- Container
- JACC. Case reports
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jaccas.2026.110244,
title = {Neurohormonal Therapy in Patients With Transthyretin Cardiac Amyloidosis: Is it an Option?},
author = {Enríquez-Vázquez D and Antúnez-Ballesteros M and Barge-Caballero G and Paniagua-Martín MJ and Padilla-Bautista M and González-Montes M and Couto-Mallón D and Vázquez-Rodríguez JM and Barge-Caballero E and Crespo-Leiro MG},
year = {2026},
journal = {JACC. Case reports},
doi = {10.1016/j.jaccas.2026.110244},
url = {https://doi.org/10.1016/j.jaccas.2026.110244}
}RIS
TY - JOUR TI - Neurohormonal Therapy in Patients With Transthyretin Cardiac Amyloidosis: Is it an Option? AU - Enríquez-Vázquez D AU - Antúnez-Ballesteros M AU - Barge-Caballero G AU - Paniagua-Martín MJ AU - Padilla-Bautista M AU - González-Montes M AU - Couto-Mallón D AU - Vázquez-Rodríguez JM AU - Barge-Caballero E AU - Crespo-Leiro MG PY - 2026 JO - JACC. Case reports DO - 10.1016/j.jaccas.2026.110244 UR - https://doi.org/10.1016/j.jaccas.2026.110244 ER -
APA
D, E., M, A., G, B., MJ, P., M, P., M, G., D, C., JM, V., E, B., & MG, C. (2026). Neurohormonal Therapy in Patients With Transthyretin Cardiac Amyloidosis: Is it an Option?. JACC. Case reports. https://doi.org/10.1016/j.jaccas.2026.110244
Source records
- pubmed · retrieved 2026-09-26T20:50:05.697Z